Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
Source: Recursion PharmaceuticalsAI drug pioneer Recursion Pharmaceuticals said Wednesday that one of its experimental treatments hit a key milestone.Recursion was able to use its artificial intelligence-enabled drug discovery platform to...